1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. Ontario >
  6. Kendle International Acquires DecisionLine Clinical Research

M&A Deal Summary

Kendle International Acquires DecisionLine Clinical Research

On June 2, 2008, Kendle International acquired life science company DecisionLine Clinical Research

Acquisition Highlights
  • This is Kendle International’s 1st transaction in the Life Science sector.
  • This is Kendle International’s 1st transaction in Canada.
  • This is Kendle International’s 1st transaction in Ontario.

M&A Deal Summary
Date 2008-06-02
Target DecisionLine Clinical Research
Sector Life Science
Buyer(s) Kendle International
Deal Type Add-on Acquisition

Target

DecisionLine Clinical Research

Toronto, Ontario, Canada
DecisionLine Clinical Research Corp. is an early-phase clinical research organization conducts Phase I studies focusing on central nervous system drugs and also does human abuse liability studies and abuse potential and risk mitigation assessments.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Kendle International

Cincinnati, Ohio, United States
Category Company
Sector Life Science
DESCRIPTION

Kendle International Inc., a clinical research organization, provides Phase I-IV clinical development services on a contract basis to the biopharmaceutical industry worldwide.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Ontario M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2008 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal